Trial results with new kinase drugs Imbruvica and Idelalisib with relapsed indolent or follicular lymphoma, January 2014 Newsletter, p. 12-16.
Keputusan percubaan dengan dadah kinase baru Imbruvica dan Idelalisib dengan kambuh limfoma malas atau folikel, Januari 2014 Surat Berita, p. 12-16.
Example taken from data source: CCAligned_v1 
> 
Translate Text 
Translate Files